Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
28.32
-0.03 (-0.11%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,069 employees as of December 31, 2024. The number of employees increased by 142 or 15.32% compared to the previous year.
Employees
1,069
Change (1Y)
142
Growth (1Y)
15.32%
Revenue / Employee
$659,624
Profits / Employee
-$424,600
Market Cap
4.51B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
IONS News
- 16 days ago - Ionis to host expert panel discussion on sHTG - Business Wire
- 19 days ago - Ionis to present at upcoming investor conferences - Business Wire
- 24 days ago - Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S. - Business Wire
- 5 weeks ago - Ono Enters into License Agreement with Ionis Pharmaceuticals for Sapablursen for the Treatment of Polycythemia Vera - Business Wire
- 5 weeks ago - Ionis and Ono announce global license agreement for sapablursen in polycythemia vera - Business Wire
- 5 weeks ago - WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy - Business Wire
- 2 months ago - New positive donidalorsen data to be presented at AAAAI/WAO Joint Congress highlight sustained HAE attack rate reduction and disease control - Business Wire
- 2 months ago - Ionis Pharmaceuticals, Inc. (IONS) Q4 2024 Earnings Call Transcript - Seeking Alpha